Prognostic Utility of Prechemoradiotherapy Albumin-to-Alkaline Phosphatase Ratio in Unresectable Locally Advanced Pancreatic Carcinoma Patients

Table 2

Outcomes of uni- and multivariate analyses.

Factor	PFS			OS
	Univariate value	Multivariate value	HR	Univariate value	Multivariate value	HR
Age group (<70 vs. ≥70 years)	0.39	—	—	0.43	—	—
Gender (female vs. male)	0.65	—	—	0.78	—	—
ECOG (0 vs. 1)	0.82	—	—	0.80	—	—
Tumor location (H vs. B/T)	0.67	—	—	0.79	—	—
N stage (0 vs. 1-2)	0.003	0.006	1.87	0.004	0.005	1.78
CA 19-9 (<90 vs. ≥90 U/m/L)	0.006	0.009	1.56	0.008	0.012	1.48
AAPR (<0.46 vs. ≥0.46)	0.005	0.003	2.21	0.001	0.002	2.47

Abbreviations: PFS: progression-free survival; OS: overall survival; HR: hazard ratio; ECOG: Eastern Cooperative Oncology Group; H: head; B/T: body/tail; N stage: nodal stage; CA 19-9: cancer antigen 19-9; AAPR: albumin-to-alkaline phosphatase ratio.